Evotec SE 和 Variant Bio 合作探索纤维化治疗方法。 Evotec SE and Variant Bio partner to discover fibrosis treatments .

Evotec SE 和 Variant Bio 合作探索目前无法治愈的纤维化相关疾病的治疗方法。 Evotec SE and Variant Bio partner to discover treatments for fibrosis-related diseases with no current cure. 利用 Variant Bio 的基因组平台和 Evotec 的药物发现专业知识，他们将识别针对关键纤维化途径的小分子，并推进临床候选药物的研发。 Using Variant Bio's genomic platform and Evotec's drug discovery expertise, they will identify small molecules targeting key fibrotic pathways, progressing towards clinical candidates. 风险共担合作伙伴关系抵消了 Variant Bio 早期药物开发成本，并分享了未来的收益。 The risk-sharing partnership offsets Variant Bio's early drug development costs for a share of future upside.